Laurent Castor, Vice-President – SEQENS Specialty Ingredients
Click HERE to download the PDF version
SEQENS STORY STARTS IN 2003. SINCE THEN, THE GROUP HAS GROWN A LOT, THANKS TO SEVERAL ACQUISITIONS, BECOMING A GLOBAL PLAYER IN PHARMACEUTICAL SYNTHESIS AND SPECIALTY INGREDIENTS. CAN YOU GO THROUGH THE MOST IMPORTANT STEPS OF THIS DEVELOPMENT?
Since its foundation, the underlying strategic principle at SEQENS has been to enrich its portfolio with activities bringing added value, resilience and growth potential, as well as high barriers to entry, whether regulatory or technological. As of 2011, we have made the choice to focus on two key markets: pharma synthesis and specialty ingredients in attractive markets such as healthcare, cosmetics, electronics, environment, food, fine chemicals, lubricant additives, etc.
From this point, we have developed across three strategic axes. We have enric ......